These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7966218)

  • 41. Characteristics of Staphylococcus aureus strains isolated from clinical and non-clinical human sources in Trinidad: susceptibility to bacteriophages and antimicrobial agents, and toxigenicity.
    Adesiyun AA; Prabhakar P; Ali C; Lewis M
    Zentralbl Bakteriol; 1995 Oct; 282(4):519-32. PubMed ID: 9810676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth.
    van Langevelde P; van Dissel JT; Meurs CJ; Renz J; Groeneveld PH
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1682-5. PubMed ID: 9257741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
    Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
    Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N; Wallach U
    Infection; 1987; 15(5):351-3. PubMed ID: 3692606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amino acid requirements of Staphylococcus aureus strains from Germany and Austria that produce toxic shock syndrome toxin-1 (TSST-1).
    Dickgiesser N; Eppli P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):1-7. PubMed ID: 3394445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.
    Robbins RN; Reiser RF; Hehl GL; Bergdoll MS
    J Clin Microbiol; 1987 Aug; 25(8):1446-9. PubMed ID: 3624442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of toxic shock syndrome toxin-1 production in Staphylococcus aureus strains isolated in Denmark between 1959 and 1990.
    Ejlertsen T; Jensen A; Lester A; Rosdahl VT
    Scand J Infect Dis; 1994; 26(5):599-604. PubMed ID: 7855557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of a toxic shock syndrome toxin variant by Staphylococcus aureus strains associated with sheep, goats, and cows.
    Ho G; Campbell WH; Bergdoll MS; Carlson E
    J Clin Microbiol; 1989 Sep; 27(9):1946-8. PubMed ID: 2778060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on production of toxic shock syndrome toxin in Staphylococcus aureus isolated from clinical specimens].
    Kawakami H; Yamada Y
    Kansenshogaku Zasshi; 1986 Feb; 60(2):133-40. PubMed ID: 3090164
    [No Abstract]   [Full Text] [Related]  

  • 51. Binding of type-I and type-II collagens to Staphylococcus aureus strains isolated from patients with toxic shock syndrome compared to other staphylococcal infections.
    Naidu AS; Ekstrand J; Wadström T
    FEMS Microbiol Immunol; 1989 Mar; 1(4):219-27. PubMed ID: 2629906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of sucrose and silver on Staphylococcus aureus biofilms.
    Akiyama H; Yamasaki O; Kanzaki H; Tada J; Arata J
    J Antimicrob Chemother; 1998 Nov; 42(5):629-34. PubMed ID: 9848447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion.
    Mills JT; Parsonnet J; Tsai YC; Kendrick M; Hickman RK; Kaśs EH
    J Infect Dis; 1985 Jun; 151(6):1158-61. PubMed ID: 3998512
    [No Abstract]   [Full Text] [Related]  

  • 54. Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
    McNamara PJ; Syverson RE; Milligan-Myhre K; Frolova O; Schroeder S; Kidder J; Hoang T; Proctor RA
    Antimicrob Agents Chemother; 2009 May; 53(5):1898-906. PubMed ID: 19223628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
    Yarwood JM; Schlievert PM
    J Clin Microbiol; 2000 May; 38(5):1797-803. PubMed ID: 10790102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions.
    Stingley RL; Liu H; Mullis LB; Elkins CA; Hart ME
    J Microbiol Methods; 2014 Nov; 106():57-66. PubMed ID: 25135489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus.
    Weckbach LS; Thompson MR; Staneck JL; Bonventre PF
    J Clin Microbiol; 1984 Jul; 20(1):18-22. PubMed ID: 6430953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons.
    Fischetti VA; Chapman F; Kakani R; James J; Grun E; Zabriskie JB
    Rev Infect Dis; 1989; 11 Suppl 1():S176-81. PubMed ID: 2928634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial efficacy of biocides tested on skin using an ex-vivo test.
    Maillard JY; Messager S; Veillon R
    J Hosp Infect; 1998 Dec; 40(4):313-23. PubMed ID: 9868624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.